Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Abhishek Kapoor Article rating: 3.6

The market opened in the green on February 6, 2020, overall volumes in futures & options currently stand at 2.74 crore contracts with a turnover of Rs. 19,60,373.95 crore.

Sagar Cements report 4.66 per cent production rise in January
Sagar Cements report 4.66 per cent production rise in January

Sagar Cements report 4.66 per cent production rise in January

Nidhi Jani Article rating: 4.0

The company’s consolidated cement production/purchase for January 2020 stood at 3,16,657 MT, up by 4.66 per cent, as compared to 3,02,558 MT produced in January, 2019.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Abhishek Kapoor Article rating: 4.6

The market opened in the green on February 6, 2020, overall volumes in futures & options currently stand at 2.74 crore contracts with a turnover of Rs. 19,60,373.95 crore.

Vaishali Pharma gets registration for 3 products in Myanmar
Vaishali Pharma gets registration for 3 products in Myanmar

Vaishali Pharma gets registration for 3 products in Myanmar

Apurva Joshi Article rating: 3.3

Vaishali Pharma Limited has received a registration for three products including VMOX CV-1200, VMOX CV-600, and CYBUFIN-1,500 in Myanmar market. These products have a good demand in the local market of Myanmar.

Ten stocks close to their 52-week high
Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

Abhishek Kapoor Article rating: 3.7

The market opened in the green on February 6, 2020. The previous trading session witnessed the Sensex going up by 353.28 points to end at 41,142.66 and the Nifty was up by 109.50 points to close at 12,089.15. 

Lupin receives USFDA nod for Leflunomide tablets
Lupin receives USFDA nod for Leflunomide tablets

Lupin receives USFDA nod for Leflunomide tablets

Anthony Fernandes Article rating: 5.0

Pharma major-Lupin Limited announced, after the trading hours on Wednesday, that it has received approval from the United States Food and Drug Administration (USFDA) for its Leflunomide tablets USP, 10 mg and 20 mg. The drug is used for treating adults with active rheumatoid arthritis.

Ten stocks close to their 52-week low
Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Abhishek Kapoor Article rating: 5.0

The market opened in the green on February 6, 2020. The previous trading session witnessed the Sensex going up by 353.28 points to end at 41,142.66 and the Nifty was up by 109.50 points to close at 12,089.15. 

Index trend and stocks in action on February 06, 2020
Index trend and stocks in action on February 06, 2020

Index trend and stocks in action on February 06, 2020

Karan Dsij Article rating: 3.5

A V-shaped recovery, which we have witnessed from the lower levels, is nearing a crucial mark and some consolidation at the current levels is important before the next leap. At the same, time it is important for the bulls to hold 11,920 mark. Stocks in news: ITI, Lupin, Sagar Cement.

RBI Monetary Policy & Q3 results in focus
RBI Monetary Policy & Q3 results in focus

RBI Monetary Policy & Q3 results in focus

Karan Dsij Article rating: 3.0

In the last session, the bulls scored a hat-trick of gains and reclaimed the 12,000 mark on Nifty. On Thursday, the pitch is firm for the bulls to bat on and extend its upmove for the fourth straight day as global cues are cheerful. However, SGX Nifty in the early trend is indicating a cautious start ahead of the RBI’s Monetary Policy Committee’s policy outcome.

Tax Planning: Common mistakes to avoid
Tax Planning: Common mistakes to avoid

Tax Planning: Common mistakes to avoid

Henil Shah Article rating: 5.0

In the season of tax saving, avoid some of the common mistakes that might hurt you in the future. Read on to find out more about these mistakes.

RSS
First29002901290229032905290729082909Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR